PAR
Click for more information
0.00% 27.5¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-246

  1. Denial
    9,687 Posts.
    lightbulb Created with Sketch. 1234
    clock Created with Sketch.
    21/10/21
    14:55
    Post #: 56972514
    To be fair to shareholder showing some concern with PR...............they're likely to be outcome based individuals.

    What happened to the peer review of 2B data that was due be end of June? This to me will provide more reassurance we're onto a winner than IND opening


    PAR Price at posting: $1.89 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
ENR Encounter Resources flags latest niobium hits in fresh assay data
right-arrow Created with Sketch.
I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
HCH Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
right-arrow Created with Sketch.
PMT High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
27.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $96.19M
Open High Low Value Volume
27.5¢ 28.5¢ 27.5¢ $32.90K 119.4K

Buyers (Bids)

No. Vol. Price($)
3 15544 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 12772 5
View Market Depth
Last trade - 14.00pm 11/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.